Succesful use of methylene blue in a patient with refractory shock on veno-arterial extracorporeal membrane oxygenation
Authors:
M. Pořízka 1; J. Kunstýř 1; P. Kopecký 1; M. Balík 1
Authors place of work:
Klinika anesteziologie, resuscitace a intenzivní medicíny, Všeobecná fakultní nemocnice v Praze, 1. lékařská fakulta, Univerzita Karlova
1
Published in the journal:
Anest. intenziv. Med., 28, 2017, č. 5, s. 305-308
Category:
Intesive Care Medicine - Case Report
Summary
Refractory circulatory shock is associated with excessive mortality in critically ill patients. Non-adrenergic vasopressors, including methylene blue, are often considered as an adjuvant therapy to the ordinary vasopressor treatment. In this case report we present a case of successful use of methylene blue reversing refractory septic shock in a patient on veno-arterial extracorporeal membrane oxygenation due to septic cardiomyopathy.
Keywords:
methylene blue – distributive shock – refractory vasoplegia – cardiomyopathy – extracorporeal membrane oxygenation
Zdroje
1. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL. SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–789. doi: 10.1056/NEJMoa0907118.
2. Bassi E, Park M, Azevedo LC. Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract. 2013;2013:654–708. doi: 10.1155/2013/654708.
3. Jenkins CR, Gomersall CD, Leung P, Joynt GM. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesth Intensive Care. 2009;37:286–9.
4. Belletti A, Musu M, Silvetti S, Saleh O, Pasin L, Monaco F, Hajjar LA, Fominskiy E, Finco G, Zangrillo A, Landoni G. Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials. PLoS One. 2015;10:e0142605. doi: 10.1371/journal.pone.0142605.
5. Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS One.;108:e0129305. doi: 10.1371/journal.pone.0129305.
6. Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol. 2013;9:242–9. doi: 10.1007/s13181-013-0298-7.
7. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.
8. Price S, Anning PB, Mitchell JA, Evans TW. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J. 1999;20:715–24.
9. Huang CT, Tsai YJ, Tsai PR, Ko WJ. Extracorporeal membrane oxygenation resuscitation in adult patients with refractory septic shock. J Thorac Cardiovasc Surg. 2013;146: 1041–1046.
Štítky
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineČlánok vyšiel v časopise
Anaesthesiology and Intensive Care Medicine
2017 Číslo 5
Najčítanejšie v tomto čísle
- Succesful use of methylene blue in a patient with refractory shock on veno-arterial extracorporeal membrane oxygenation
- Cognitive disorders in perioperative and intensive care
- Neurotoxicity of anaesthetics on the developing brain
- The endothelial glycocalyx and fluid therapy in critical care and perioperative medicine